These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 17885304)

  • 1. Rapamycin reduces CCR5 mRNA levels in macaques: potential applications in HIV-1 prevention and treatment.
    Gilliam BL; Heredia A; Devico A; Le N; Bamba D; Bryant JL; Pauza CD; Redfield RR
    AIDS; 2007 Oct; 21(15):2108-10. PubMed ID: 17885304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
    Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
    J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin enhances aplaviroc anti-HIV activity: implications for the clinical development of novel CCR5 antagonists.
    Latinovic O; Heredia A; Gallo RC; Reitz M; Le N; Redfield RR
    Antiviral Res; 2009 Jul; 83(1):86-9. PubMed ID: 19501260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemokine CCL5 regulates the in vivo cell surface expression of its receptor, CCR5.
    Lin YL; Mettling C; Portalès P; Rouzier R; Clot J; Reynes J; Corbeau P
    AIDS; 2008 Jan; 22(3):430-2. PubMed ID: 18195571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of first, second, and third trimester placental factors on CD4, CCR5, and CXCR4 expression in human peripheral blood lymphocytes.
    Li LP; Kang JL; Xia W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jun; 33(6):461-7. PubMed ID: 18599991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of genital ulcer disease on HIV-1 coreceptor expression in the female genital tract.
    Sheffield JS; Wendel GD; McIntire DD; Norgard MV
    J Infect Dis; 2007 Nov; 196(10):1509-16. PubMed ID: 18008231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of progesterone levels and pregnancy on HIV-1 coreceptor expression.
    Sheffield JS; Wendel GD; McIntire DD; Norgard MV
    Reprod Sci; 2009 Jan; 16(1):20-31. PubMed ID: 19144888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
    Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
    Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin selectively inhibits expression of an inducible keratin (K6a) in human keratinocytes and improves symptoms in pachyonychia congenita patients.
    Hickerson RP; Leake D; Pho LN; Leachman SA; Kaspar RL
    J Dermatol Sci; 2009 Nov; 56(2):82-8. PubMed ID: 19699613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation.
    Murooka TT; Rahbar R; Fish EN
    Biochem Biophys Res Commun; 2009 Sep; 387(2):381-6. PubMed ID: 19607806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ CCR5+ T-cell dynamics during simian immunodeficiency virus infection of Chinese rhesus macaques.
    Monceaux V; Viollet L; Petit F; Cumont MC; Kaufmann GR; Aubertin AM; Hurtrel B; Silvestri G; Estaquier J
    J Virol; 2007 Dec; 81(24):13865-75. PubMed ID: 17898067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and clinical investigation of the relationship between CCR5 receptor occupancy and anti-HIV activity of Aplaviroc.
    Demarest JF; Sparks SS; Schell K; Shibayama S; McDanal CB; Fang L; Adkison KK; Shachoy-Clark A; Piscitelli SC
    J Clin Pharmacol; 2008 Oct; 48(10):1179-88. PubMed ID: 18676693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
    Li J; Xia J; Zhang K; Xu L
    J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative activity of "function sparing" HIV-1 entry inhibitors on viral entry and CCR5 internalization: is allosteric functional selectivity a valuable therapeutic property?
    Muniz-Medina VM; Jones S; Maglich JM; Galardi C; Hollingsworth RE; Kazmierski WM; Ferris RG; Edelstein MP; Chiswell KE; Kenakin TP
    Mol Pharmacol; 2009 Mar; 75(3):490-501. PubMed ID: 19064629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia.
    Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
    Transplantation; 2007 Oct; 84(8):1029-36. PubMed ID: 17989609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative effect of rapamycin on human T-cell leukemia cell line Jurkat by cell cycle arrest and telomerase inhibition.
    Zhao YM; Zhou Q; Xu Y; Lai XY; Huang H
    Acta Pharmacol Sin; 2008 Apr; 29(4):481-8. PubMed ID: 18358095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirolimus ameliorates the enhanced expression of metalloproteinases in a rat model of autosomal dominant polycystic kidney disease.
    Berthier CC; Wahl PR; Le Hir M; Marti HP; Wagner U; Rehrauer H; Wüthrich RP; Serra AL
    Nephrol Dial Transplant; 2008 Mar; 23(3):880-9. PubMed ID: 18042615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin.
    Hoogduijn MJ; Crop MJ; Korevaar SS; Peeters AM; Eijken M; Maat LP; Balk AH; Weimar W; Baan CC
    Transplantation; 2008 Nov; 86(9):1283-91. PubMed ID: 19005411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term administration of rapamycin reduces adiposity, but impairs glucose tolerance in high-fat diet-fed KK/HlJ mice.
    Chang GR; Wu YY; Chiu YS; Chen WY; Liao JW; Hsu HM; Chao TH; Hung SW; Mao FC
    Basic Clin Pharmacol Toxicol; 2009 Sep; 105(3):188-98. PubMed ID: 19496779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin inhibits PAI-1 expression and reduces interstitial fibrosis and glomerulosclerosis in chronic allograft nephropathy.
    Pontrelli P; Rossini M; Infante B; Stallone G; Schena A; Loverre A; Ursi M; Verrienti R; Maiorano A; Zaza G; Ranieri E; Gesualdo L; Ditonno P; Bettocchi C; Schena FP; Grandaliano G
    Transplantation; 2008 Jan; 85(1):125-34. PubMed ID: 18192922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.